Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles
- PMID: 17613700
- DOI: 10.1080/08982100701375118
Animal models of complement-mediated hypersensitivity reactions to liposomes and other lipid-based nanoparticles
Abstract
Intravenous injection of some liposomal drugs, diagnostic agents, micelles and other lipid-based nanoparticles can cause acute hypersensitivity reactions (HSRs) in a high percentage (up to 45%) of patients, with hemodynamic, respiratory and cutaneous manifestations. The phenomenon can be explained with activation of the complement (C) system on the surface of lipid particles, leading to anaphylatoxin (C5a and C3a) liberation and subsequent release reactions of mast cells, basophils and possibly other inflammatory cells in blood. These reactions can be reproduced and studied in pigs, dogs and rats, animal models which differ from each other in sensitivity and spectrum of symptoms. In the most sensitive pig model, a few miligrams of liposome (phospholipid) can cause anaphylactoid shock, characterized by pulmonary hypertension, systemic hypotension, decreased cardiac output and major cardiac arrhythmias. Pigs also display cutaneous symptoms, such as flushing and rash. The sensitivity of dogs to hemodynamic changes is close to that of pigs, but unlike pigs, dogs also react to micellar lipids (such as Cremophor EL) and their response includes pronounced blood cell and vegetative neural changes (e.g., leukopenia followed by leukocytosis, thrombocytopenia, fluid excretions). Rats are relatively insensitive inasmuch as hypotension, their most prominent response to liposomes, is induced only by one or two orders of magnitude higher phospholipid doses (based on body weight) compared to the reactogenic dose in pigs and dogs. It is suggested that the porcine and dog models are applicable for measuring and predicting the (pseudo)allergic activity of particulate "nanodrugs".
Similar articles
-
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses.J Control Release. 2014 Dec 10;195:2-10. doi: 10.1016/j.jconrel.2014.08.009. Epub 2014 Aug 19. J Control Release. 2014. PMID: 25148822
-
A porcine model of complement-mediated infusion reactions to drug carrier nanosystems and other medicines.Adv Drug Deliv Rev. 2012 Dec;64(15):1706-16. doi: 10.1016/j.addr.2012.07.005. Epub 2012 Jul 20. Adv Drug Deliv Rev. 2012. PMID: 22820530 Review.
-
Complement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs, and radiocontrast agents.Crit Rev Ther Drug Carrier Syst. 2001;18(6):567-606. Crit Rev Ther Drug Carrier Syst. 2001. PMID: 11789676 Review.
-
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy.Molecules. 2019 Sep 9;24(18):3283. doi: 10.3390/molecules24183283. Molecules. 2019. PMID: 31505853 Free PMC article.
-
Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions.ACS Nano. 2019 Aug 27;13(8):9315-9324. doi: 10.1021/acsnano.9b03942. Epub 2019 Aug 6. ACS Nano. 2019. PMID: 31348638
Cited by
-
Advancements in Macrophage-Targeted Drug Delivery for Effective Disease Management.Int J Nanomedicine. 2023 Nov 23;18:6915-6940. doi: 10.2147/IJN.S430877. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38026516 Free PMC article. Review.
-
Quantitative Assessment of Inflammation in a Porcine Acute Terminal Ileitis Model: US with a Molecularly Targeted Contrast Agent.Radiology. 2015 Sep;276(3):809-17. doi: 10.1148/radiol.2015142478. Epub 2015 May 12. Radiology. 2015. PMID: 25965901 Free PMC article.
-
Unintended effects of drug carriers: Big issues of small particles.Adv Drug Deliv Rev. 2018 May;130:90-112. doi: 10.1016/j.addr.2018.06.023. Epub 2018 Jul 3. Adv Drug Deliv Rev. 2018. PMID: 30149885 Free PMC article. Review.
-
Recent developments in liposome-based veterinary therapeutics.ISRN Vet Sci. 2013 Oct 10;2013:167521. doi: 10.1155/2013/167521. ISRN Vet Sci. 2013. PMID: 24222862 Free PMC article. Review.
-
Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment.J Pers Med. 2018 Jan 23;8(1):6. doi: 10.3390/jpm8010006. J Pers Med. 2018. PMID: 29360800 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical